Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zaoshen Anshen Oral Liquid is a patented Traditional Chinese Medicine (TCM) developed by Hebei Yiling Pharmaceutical for the treatment of sleep disorders, specifically insomnia. The formulation is designed according to TCM principles to nourish the heart and kidney yin, thereby calming the spirit (An Shen) and improving sleep quality. Its primary active components are derived from herbal extracts, including *Semen Ziziphi Spinosae* (Sour Jujube Seed) and *Fructus Mori* (Mulberry). It is indicated for patients presenting with insomnia, dream-disturbed sleep, dizziness, tinnitus, and palpitations associated with a deficiency in heart and kidney yin. The product was approved by the China National Medical Products Administration (NMPA) and is part of Yiling's portfolio of evidence-based TCM products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zaoshen anshen koufuye.